Table 2 Baseline laboratory and respiratory function data for patients with COVID-19 and pneumothorax
From: Pneumothorax in COVID-19 disease- incidence and clinical characteristics
Case | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
Baseline Laboratory/ Inflammatory Markers Data | ||||||
WBC (K/mm3) | 8.1 | 8.3 | 4.3 | 4.5 | 11.5 | 7.4 |
Absolute Lymphocyte Count (K/mm3) | 0.6 | 0.8 | 0.5 | 0.6 | 0.5 | 0.7 |
Absolute Neutrophil Count (K/mm3) | 4.5 | 7.0 | 3.1 | 3.4 | 7.8 | 6.5 |
CRP (mg/L) | 13.1 | 13.6 | 11.3 | 16.2 | 8.7 | 16.5 |
LDH (U/L) | 331 | 472 | 148 | 200 | 481 | 386 |
D- Dimer (ng/ml) | 695 | 788 | 662 | 993 | 1164 | 6947 |
Ferritin (ng/ml) | 676 | 775 | 419 | 268 | 834 | 446 |
IL-6 (pg/ml) | 80.37 | 70.39 | < 1.4 | 6.69 | 11.95 | – |
Baseline Respiratory Function | ||||||
SF ratio | 215 | 156 | 218 | 133 | 92 | 155 |